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Ablation of Familial Atrial
Fibrillation. Favorable Long-
Term Outcome
To the Editor:
We present the case of a 39-year-old man with no risk
factors for cardiovascular disease. He had a 6-year history
of paroxysmal atrial flutter and fibrillation, documented by
electrocardiogram and Holter. He complained of daily epi-
sodes of rapid, irregular palpitation. There was no radio-
graphic or echographic evidence of structural myocardial
abnormalities. Other members of the family (a grandmother,
his father, a brother and at least two uncles) had a history of
atrial fibrillation that had begun at an early age (Figure). All
of them had been diagnosed as having “isolated” atrial fibri-
llation. Our patient had been treated unsuccessfully with dil-
tiazem, flecainide, and propafenone. An electrophysiologi-
cal study revealed the presence of typical atrial flutter.
Radiofrequency ablation was performed and the flutter was
interrupted by bidirectional isthmus block. Treatment was
continued with flecainide at a dose of 100 mg/12 h. During
follow-up, multiple episodes of paroxysmal atrial fibrillation
were detected, and ablation of the pulmonary veins was in-
dicated. This procedure was performed with the patient in
sinus rhythm. Two electrode catheters were introduced via
right femoral vein and a third via subclavian vein. Double
transseptal catheterization was successfully performed, and
pulmonary vein potentials were recorded using a 4-mm Ma-
rinr ablation catheter (Medtronic) and a Lasso catheter (Cor-
dis). The 4 pulmonary veins were isolated (power setting:
50 W, 65ºC) and the left isthmus was ablated, although ab-
normal potentials were detected only in the left superior pul-
monary vein. After a 30-month postablation follow-up pe-
riod during which he received no antiarrhythmic therapy,
the patient did not experience palpitations and the Holter re-
cording was normal.
Ablation of atrial fibrillation constitutes a real and effecti-
ve therapeutic option in many patients with very frequent
episodes that are refractory to antiarrhythmic therapy.1-3 Fa-
milial atrial fibrillation is a heterogeneous genetic disease
that is an object of continuous research.4,5 Until now, the
prospects for the treatment of these patients were limited.
We report the case of a patient with atrial fibrillation that
could have an autosomic dominant pattern of inheritance or
could be the outcome of both parents having a recessive ge-
netic disorder. Its penetrance is apparently high. Associated
heart disease or precipitating factors were not encountered.
Brugada et al4 reported several cases of familial atrial fibri-
llation and identified the gene responsible for this disorder
on chromosome 10, although it is assumed that there are
probably a number of genetic abnormalities involved.4 In a
certain proportion of patients with atrial fibrillation, we
were unable to identify the cardiac disorder or its causes.
Many of these patients may present either a hereditary or a
de novo genetic abnormality. Catheter ablation for atrial fi-
brillation is progressively becoming accepted as an effective
technique in the treatment of refractory patients.6 The keys
to selecting the patient and the appropriate technique remain
to be determined, as is the degree of efficacy in familial ca-
ses. The isolation of the pulmonary vein orifices makes it
possible to eliminate the arrhythmogenic activity that trig-
gers or perpetuates the arrhythmia without eliminating other
possible foci. In our patient, we detected abnormal poten-
tials only in the left superior pulmonary vein, although,
given the characteristics of the case, we opted for the isola-
tion of all 4 pulmonary veins and an additional line for left
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Figure. Family tree of the patient
(who is indicated by the arrow).
Square indicates man; circle,
woman; darkened symbols, pa-
tient with atrial fibrillation; blank
symbols, asymptomatic patient
with no documented atrial fibri-
llation; shaded symbols, indeter-
minate.
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isthmus block (between left inferior pulmonary vein and the
mitral ring).
In conclusion, catheter ablation is a safe and effective
technique for the treatment of atrial fibrillation that may also
be successfully employed in patients with familial atrial fi-
brillation.
Antonio Hernández Madrid, 
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Servicio de Cardiología, Unidad de Arritmias,
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Figure. Angiographic sequence. The arrows indicate the location of
the underexpanded ring in each image. A: anterior descending coro-
nary artery prior to the interventional procedure. B: predilatation and
implantation of a stent (2.75×24 mm), showing the underexpanded
ring. C: unsuccessful postimplantation dilatation at 25 atmospheres.
D: intra-stent rotablation with a 1.75-mm olive-shaped burr. F: repea-
ted postimplantation dilatation followed by drug-eluting stent place-
ment (3.0×12-mm Taxus). F: final satisfactory angiographic result.
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